x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

 
Blog

Keys to Unblocking the Innovation Bottleneck in Research

As the clinical trial industry has evolved in the past decade, it’s invited more complexity into operations and workflows.

Read Now
6 min. read
Read more
 
Blog

Informed Consent Writing Tip Sheet

Informed consent is a centrally regulated protection for research participants. Learn the regulatory requirements for providing it. 

Read Now
8 min. read
Read more
 
Blog

How the IND 30-day Hold Impacts Clinical Trial Activities

Find out what research activities can and cannot be conducted during the Investigational New Drug (IND) 30-day hold period.

Read Now
6 min. read
Read more
 
Blog

Streamline Study Startup with Improved Site Selection & Feasibility

Identifying the best prepared and performing sites for a study is essential to success. Explore strategies to improve site selection and feasibility.

Read Now
5 min. read
Read more
 
Blog

Scale Your Training Program: Three Successful Models

Finding the best training solutions begins with understanding your organization’s training needs.

Read Now
4 min. read
Read more
 
Blog

Beginner’s Guide to 21 CFR Part 11 Compliance

FDA released regulations in 1997 outlining how 21 CFR Part 11 applies to electronic records and electronic signatures in clinical research.

Read Now
4 min. read
Read more
 
Blog

Regulatory, Clinical, and Quality Considerations for Device Research

Medical device manufacturers are facing increasingly complex pathways to successfully bring their innovative ideas to the market.

Read Now
5 min. read
Read more
 
Blog

Safe Sharps Handling When Dispensing Investigational Products

Care must be taken to avoid sharps-related injuries and exposures when preparing investigational products for clinic transportation.

Read Now
4 min. read
Read more
 
Blog

Regulatory and Ethical Considerations for eConsent in Research

If any part of your informed consent process involves an electronic component, you’re conducting eConsent.

Read Now
4 min. read
Read more
 
Blog

An Evolving Regulatory Environment for Rare and Orphan Diseases

By 1983, only 38 orphan drugs received FDA approval. Since then, the FDA has significantly changed its approach to rare and orphan diseases.

Read Now
4 min. read
Read more
 
Blog

Enhancing Research Conduct Using eConsent

The Belmont Report established informed consent parameters in 1976, but there are no federal regulations surrounding electronic consent.

Read Now
5 min. read
Read more
 
Blog

5 Questions to Ask Your Sponsor for DCT Implementation

Sponsors are uncertain about how to design a DCT to ensure efficient performance delivery, learn how to set your organization up for success.

Read Now
4 min. read
Read more